Company Information
- Type:
- Company
- Country:
- Egypt
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 28 December 2021 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Parent Company
| Country | Company Name |
|---|---|
| United Kingdom | AstraZeneca UK Ltd |
Parent Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 27-Jul-2024 | 2024 Communication on Progress | Submitted |
| 27-Dec-2023 | 2023 Communication on Progress | Submitted |
| 18-Jul-2022 | 2022 Communication on Progress | Submitted |
| 27-Jun-2022 | Communication on Progress | Advanced |
| 31-Mar-2021 | Communication on Progress 2020 | Advanced |
| 03-Apr-2020 | Communication on Progress | Advanced |
| 04-Apr-2019 | Communication on Progress AstraZeneca 2019 | Advanced |
| 23-Apr-2018 | Communication on Progress | Advanced |
| 29-Apr-2017 | Communication on Progress | Active |
| 06-Jun-2016 | Communication on Progress AstraZeneca 2016 | Active |
| 10-Jun-2015 | AstraZeneca Communication on Progress 2015 | Learner |
| 06-Mar-2015 | Grace Letter | Not applicable |
| 28-Mar-2014 | Communication on Progress 2014 | Advanced |
| 28-Mar-2013 | AstraZeneca 2012 | Advanced |
| 28-Mar-2012 | 2011 Communication on Progress | Advanced |
| 08-Apr-2011 | 2010 Communication on Progress | Advanced |
| 21-Dec-2010 | Grace Letter | Not applicable |